Drug Topics
JULY 3, 2024
Individuals who ate diets that aligned closer to DASH and Mediterranean guidelines had lower levels of plasminogen activator inhibitor-1 and homocysteine biomarkers.
PharmaVoice
JULY 3, 2024
GeoVax is developing a next-gen COVID vaccine targeting a population that’s so far been elusive: immunocompromised patients.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JULY 3, 2024
Six abstracts presented at the American Diabetes Association 84th Scientific Sessions explored how different interventions or factors can impact type 2 diabetes (T2D) management.
STAT
JULY 3, 2024
Remember when we thought Covid was a two-week illness? So does Michael Peluso, assistant professor of medicine at the University of California, San Francisco. He recalls the rush to study acute Covid infection, and the crush of resulting papers. But Peluso, an HIV researcher, knew what his team excelled at: following people over the long term.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Fierce Healthcare
JULY 3, 2024
To address behavioral health access barriers for students, California launched a program to offer incentive payments to Medi-Cal managed care plans to build capacity for behavioral health services in K-12 schools.
STAT
JULY 3, 2024
When, in April, the federal government began requiring some cows to be tested for a strain of avian flu before their herds could be moved across state lines, it seemed like an obvious step to try to track and slow the virus that had started spreading among U.S. dairy cattle. But Joe Armstrong, a veterinarian at the University of Minnesota extension school, feared the U.S.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
JULY 3, 2024
A new observational study on Wednesday reported for the first time a potential link between Novo Nordisk’s GLP-1 drugs Ozempic and Wegovy and an eye condition that can cause vision loss. After hearing anecdotes of patients on the diabetes and obesity drugs experiencing nonarteritic anterior ischemic optic neuropathy, or NAION, researchers at Massachusetts Eye and Ear analyzed data from a registry of patients at their institution to see if there was a broad trend.
Fierce Healthcare
JULY 3, 2024
LAS VEGAS—Amazon is betting big on its pharmacy arm, with the retail giant aiming to bring its focus on ease of use for consumers to the prescription drug space. | LAS VEGAS—Amazon is betting big on its pharmacy arm, with the retail giant aiming to bring its focus on ease of use for consumers to the prescription drug space.
STAT
JULY 3, 2024
While the bogus science of eugenics — the idea that the human race can be improved through selective reproduction — has been nearly universally discredited, remnants of this belief system are still alive and well in modern research. One of the most glaring examples of this is the work of academic psychologist Richard Lynn. Lynn’s work focused on researching human intelligence and the “national IQ” database he compiled on IQ scores from many countries has been c
Fierce Healthcare
JULY 3, 2024
It is estimated that up to 20% of people globally are neurodivergent. Many neurodivergent individuals, including those with autism, have unique sensory needs. | This week on "Podnosis," Anastassia Gliadkovskaya explores how Jefferson Health's new pavilion incorporates innovative, inclusive features for neurodivergent individuals.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
JULY 3, 2024
The test can be performed in settings that operate under the Clinical Laboratory Improvement Amendments waiver, including community pharmacies.
STAT
JULY 3, 2024
GSK and CureVac have restructured an ongoing partnership that gives the British pharma giant control over the development of experimental mRNA-based Covid and flu vaccines, the companies said Wednesday. CureVac, the German biotech that focuses on mRNA vaccines, will receive an initial payment of €400 million upfront ($430 million) from GSK, and is eligible for another €1.05 billion ($1.1 billion) in future payments if certain milestones are hit.
Pharmacy Times
JULY 3, 2024
Palliative care may help reduce symptoms and improve quality-of-life for patients with cardiovascular disease.
STAT
JULY 3, 2024
More than two dozen Medicare Advantage insurers received higher quality marks for 2024, based on a STAT review of new data released July 2 by the federal government. Ten health insurance companies, including UnitedHealth Group’s UnitedHealthcare and CVS Health’s Aetna, received critical upgrades in some of their offerings that will allow them to earn hundreds of millions of dollars in extra taxpayer-funded bonuses.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
pharmaphorum
JULY 3, 2024
Frontiers Health, a prominent event in health innovation, has unveiled the foundational pillars that will define its legacy and future trajectory. The announcement of these pillars precedes their global conference, scheduled for the 17th and 18th of October in Berlin.
STAT
JULY 3, 2024
This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. Taking time off is nice, but returning for a July 4-shortened workweek is a bit discombobulating. Speaking of which, I’m landing in your inbox a day early because of the holiday.
pharmaphorum
JULY 3, 2024
GSK has upgraded its longstanding alliance with CureVac on mRNA-based vaccines for respiratory infections, paying €400 million ($429 million) upfront for global rights to its influenza and COVID-19 jabs.
Pharmacy Times
JULY 3, 2024
Validating language proficiency in bilingual pharmacists is crucial for patient safety and communication.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
JULY 3, 2024
Eli Lilly finally has FDA approval for its amyloid-busting Alzheimer’s disease therapy donanemab and will launch it at a cost it claims could deliver savings compared to a rival therapy from Eisai/Biogen.
STAT
JULY 3, 2024
Top of the morning to you, and a fine one it is. The skies are clear, the sun is shining, and all sorts of birds are chirping outside our window. Moreover, there is a one-day break tomorrow on this side of the pond due to a holiday. So to celebrate, yes, we are firing up the coffee kettle to indulge in another cup of stimulation. Our choice today is maple bourbon.
pharmaphorum
JULY 3, 2024
Beacon Therapeutics raises $170m for a pivotal trial of its gene therapy for X-linked retinitis pigmentosa, an inherited cause of blindness
Med Ed 101
JULY 3, 2024
JE is a 77-year-old male. He reports significant constipation despite the use of three laxative medications. In this case summary, I will outline the most important medications that can contribute to constipation polypharmacy. Past medical history includes: The current constipation medications he is taking include: Other medications include: Constipation Polypharmacy Review The first thing I […] The post Constipation Polypharmacy appeared first on Med Ed 101.
pharmaphorum
JULY 3, 2024
EU is first to approve Sanofi and Regeneron's Dupixent for COPD, ending a 10-year hiatus in new therapies
Pharmafile
JULY 3, 2024
GSK and CureVac have announced that they have restructured their existing collaboration into a license agreement, which is intended to allow both companies to prioritise investment and focus their respective mRNA development programmes. The post GSK and CureVac to restructure collaboration into licensing agreement appeared first on Pharmafile.
pharmaphorum
JULY 3, 2024
ASCO 2024 interview with Andree Amelsberg providing insights and perspectives on the latest trends and developments in the industry.
Pharmaceutical Technology
JULY 3, 2024
Academic institutions and nonprofit organisations are jumping in to save access to complex gene therapies.
The Checkup by Singlecare
JULY 3, 2024
Levothyroxine, also known by brand names like Synthroid, Tirosint, and Levoxyl, is a thyroid medicine known as thyroid replacement therapy or thyroid hormone replacement. It is used in people with an underactive thyroid (hypothyroidism) and replaces the thyroid hormone the body normally makes. It is also used to treat certain types of thyroid cancer and thyroid disorders.
Fierce Healthcare
JULY 3, 2024
Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. | Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please submit the good news—or the bad—from your shop, and we will feature it here at the end of each week.
The Checkup by Singlecare
JULY 3, 2024
Lorazepam is a generic medication approved by the U.S. Food and Drug Administration ( FDA ) to treat anxiety disorders or for the short-term relief of anxiety symptoms. As a benzodiazepine, lorazepam has serious risks, including drug abuse, drug dependence, and fatal overdoses. Due to these risks, lorazepam is classified as a Schedule IV controlled substance by the U.S.
pharmaphorum
JULY 3, 2024
Frontiers Health, a prominent event in health innovation, has unveiled the foundational pillars that will define its legacy and future trajectory. The announcement of these pillars precedes their global conference, scheduled for the 17th and 18th of October in Berlin.
The Checkup by Singlecare
JULY 3, 2024
Adderall (amphetamine/dextroamphetamine) is a brand-name prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat attention deficit hyperactivity disorder ( ADHD ) and narcolepsy. Adderall is generally used in combination with other treatment methods, such as behavioral therapy and educational interventions. In some cases, people who take Adderall may notice that after some time, it feels like the medicine is not working as well as it used to.
STAT
JULY 3, 2024
Artificial intelligence has the potential to revolutionize how drugs are discovered and change how hospitals deliver care to patients. But AI also comes with the risk of irreparable harm and perpetuating historic inequities. Would-be health care AI regulators have been spinning in circles trying to figure out how to use AI safely. Industry bodies, investors, Congress, and federal agencies are unable to agree on which voluntary AI validation frameworks will help ensure that patients are safe.
Fierce Pharma
JULY 3, 2024
After more than a decade with no treatment advances for chronic obstructive pulmonary disease (COPD), two have been approved by regulators on either side of the Atlantic within a week. | After more than a decade with no treatment advances for chronic obstructive pulmonary disease (COPD), two have been approved by regulators on either side of the Atlantic within a week.
Expert insights. Personalized for you.
492 
Let's personalize your content